Back
Novo Nordisk AS Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
18
NVO
Novo Nordisk AS
Last Price:
$66.14
Seasonality Move:
4.1%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 66.39 | Sell |
20-day SMA: | 64.27 | Buy |
50-day SMA: | 69.49 | Sell |
200-day SMA: | 99 | Sell |
8-day EMA: | 65.78 | Sell |
20-day EMA: | 65.77 | Sell |
50-day EMA: | 69.9 | Sell |
200-day EMA: | 91.17 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 45.66 | Sell |
Chaikin Money Flow: | -7719945 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.36 - 67.2) | Buy |
Bollinger Bands (100): | (67.24 - 88.18) | Sell |
Novo Nordisk AS Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 64.41 while NVO 8-day simple moving average is 66.39, which is a Sell signal.
-
The stock price of NVO is 64.41 while Novo Nordisk AS 20-day SMA is 64.27, which makes it a Buy.
-
Novo Nordisk AS 50-day simple moving average is 69.49 while NVO share price is 64.41, making it a Sell technically.
-
NVO stock price is 64.41 and Novo Nordisk AS 200-day simple moving average is 99.00, creating a Sell signal.
NVO Technical Analysis vs Fundamental Analysis
Sell
18
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NVO] share price is $64.41. The Score for NVO is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
286.2B
Price in USD:
64.41
Share Volume:
10.1M
Novo Nordisk AS 52-Week Range
52-Week High:
148.15
52-Week Low:
57.00
Sell
18
Novo Nordisk AS (NVO)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 64.41 USD today.
-
Will NVO stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 64.41 while NVO 8-day exponential moving average is 65.78, which is a Sell signal.
-
The stock price of NVO is 64.41 while Novo Nordisk AS 20-day EMA is 65.77, which makes it a Sell.
-
Novo Nordisk AS 50-day exponential moving average is 69.90 while NVO share price is 64.41, making it a Sell technically.
-
NVO stock price is 64.41 and Novo Nordisk AS 200-day simple moving average is 91.17, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.16 per share, an increase this year of $0.87 per share, and an increase next year of $0.69 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NVO Moving Average Covergence Divergence (MACD) indicator is -0.6, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 45.66, which suggest Novo Nordisk AS is oversold
-
The Bollinger Bands (25) for Novo Nordisk AS is (61.36 - 67.2), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (67.24 - 88.18), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.